Scientific Medical Equipment Reports SAR 8.3M Net Profit in Three Months 2026
EQUIPMENT HOUSE 4014.SA | 0.00 |
On 2026-05-10 15:59:30 (Saudi Time), Scientific & Medical Equipment House Co. announced its Interim financial results for the three months ended on March 31, 2026.
| Element List | Current Quarter | Similar quarter for previous year | %Change | Previous Quarter | % Change |
|---|---|---|---|---|---|
| Sales/Revenue | 192.1 | 221.7 | -13.351 | 181.9 | 5.607 |
| Gross Profit (Loss) | 25.1 | 33.3 | -24.624 | 21 | 19.523 |
| Operational Profit (Loss) | 8.6 | 13.8 | -37.681 | 2.7 | 218.518 |
| Net Profit (Loss) Attributable to Shareholders of the Issuer | 8.3 | 7.7 | 7.792 | 0.7 | 1,085.714 |
| Total Comprehensive Income Attributable to Shareholders of the Issuer | 8.3 | 7.7 | 7.792 | 0.4 | 1,975 |
| All figures are in (Millions) Saudi Arabia, Riyals | |||||
| Element List | Current Period | Similar period for previous year | %Change |
|---|---|---|---|
| Total Shareholders Equity (after Deducting Minority Equity) | 517 | 518.3 | -0.25 |
| Profit (Loss) per Share | 0.28 | 0.26 | |
| All figures are in (Millions) Saudi Arabia, Riyals | |||
| Element List | Amount | Percentage of the capital (%) | |
|---|---|---|---|
| Profit (Losses) Resulting From The Change In Investment Propertie’s Fair Value | - | - | |
| Accumulated Losses | - | - | |
| All figures are in (Millions) Saudi Arabia, Riyals | |||
Year-on-Year Performance Drivers
Sales declined 13.351% YoY to SAR 192.1 million primarily due to the completion of certain operations, maintenance, and contracting projects that had contributed SAR 63.2 million in revenue the previous year. Despite the revenue decline, net profit increased 7.792% to SAR 8.3 million, driven by decreased general and administrative expenses, reduced selling and distribution costs, and increased miscellaneous income. The revenue decrease was partially offset by SAR 4.2 million increase from subsidiaries and SAR 29.4 million from new projects.
Quarter-on-Quarter Performance Drivers
QoQ revenue increased 5.607% to 192.1 million SAR, driven by higher revenues from operations, maintenance, and contracting sectors plus increased medical device sales from new projects totaling 10.9 million SAR, partially offset by 0.8 million SAR decrease in subsidiary sales. Net profit surged 1,085.714% to 8.3 million SAR, primarily due to 3.2 million SAR increase in operating profit margin from higher sector revenues and 4.0 million SAR reduction in expected credit loss provisions from improved customer collections.
Other Items
The external auditor issued an unmodified conclusion with no additional comments, disclaimers, or adverse opinions noted. No accumulated losses were reported, and total shareholders' equity remained stable at SAR 517 million compared to SAR 518.3 million in the previous year. Earnings per share improved to SAR 0.28 from SAR 0.26 in the comparable period.
Original announcement:
https://www.saudiexchange.sa/wps/portal/saudiexchange/newsandreports/issuer-news/issuer-announcements/issuer-announcements-details/?anId=95187&anCat=1&cs=4014&locale=arImportant Notice: The announcement information and market data in this report are sourced directly from the Saudi Exchange (Tadawul). This summary is generated by Sahm’s proprietary AI model for informational purposes only. While we strive for accuracy, it should not be construed as financial advice or an investment recommendation.